Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN

Affiliations

• ¹ Department of Internal Medicine IV, University Hospital Halle, Martin-Luther University Halle-Wittenberg, Germany.
• ² Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ³ Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁴ Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Ulm, Germany.
• ⁵ Department of Otorhinolaryngology, Head and Neck Surgery, University Medicine Greifswald, Germany; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: chia-jung.busch@med.uni-greifswald.de.
• ⁶ Department of Internal Medicine IV, University Hospital Halle, Martin-Luther University Halle-Wittenberg, Germany. Electronic address: Mascha.Binder@uk-halle.de.